What's New on the FDA Drugs Site
August 5, 2016
- 0.25 Percent Bupivacaine Hydrochloride Injection, USP by Hospira: Recall - Particulate Matter
- Drug Firm Annual Registration Status Download File (updated)
- Drug Firm Annual Registration Status (updated)
- FDA Small Business Regulatory Education for Industry (REdI) Conference September 2016
- FDA Drug Shortages
- Tigecycline (Tygacil) Injection (Updated - Currently in Shortage)
- National Drug Code Directory
- Ulcerative Colitis: Clinical Trial Endpoints Guidance for Industry (PDF - 565KB)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
New and Generic Drug Approvals
August 4, 2016
| Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
|---|---|---|---|---|
| Depo-Subq Provera 104 | medroxyprogesterone acetate | Injectable;Subcutaneous | Pharmacia and Upjohn | Manufacturing Change or Addition |
| Duloxetine Hydrochloride | duloxetine hydrochloride | Capsule, Delayed Rel Pellets;Oral | Hetero Labs Ltd Iii | Approval |
| Fragmin | dalteparin sodium | Injectable;Injection | Pfizer Inc | Labeling Revision |
| Fragmin | dalteparin sodium | Injectable;Subcutaneous | Pfizer Inc | Labeling Revision |
| Kyprolis | carfilzomib | Powder;Intravenous | Onyx Therap | Labeling Revision |
| Pancreaze | pancrelipase (amylase;lipase;protease) | Capsule, Delayed Release;Oral | Janssen Pharms | Manufacturing Change or Addition |
| Sterile Water | sterile water for irrigation | Liquid;Irrigation | Baxter Hlthcare | Manufacturing Change or Addition |
| Zurampic | lesinurad | Tablet;Oral | Ardea Biosciences | Manufacturing Change or Addition |
Searching the Orange Book is now faster and easier with our new mobile app!
Download Orange Book Express



Belum ada tanggapan untuk "CDER New August 8, 2016"
Post a Comment